End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
104.80 CHF | +0.82% | -1.46% | +13.91% |
Nov. 21 | Robertet: Fonds Stratégique de Participations tops 5% mark | CF |
Nov. 21 | DSM-Firmenich Exits Stake in Fragrances, Flavors Company Robertet | MT |
Capitalization | 27.8B 29.18B 25.86B 23.07B 41.05B 2,472B 45.18B 321B 119B 1,013B 110B 107B 4,352B | P/E ratio 2024 * |
59.9x | P/E ratio 2025 * | 35.3x |
---|---|---|---|---|---|
Enterprise value | 30.86B 32.39B 28.71B 25.61B 45.57B 2,745B 50.15B 357B 132B 1,125B 122B 119B 4,832B | EV / Sales 2024 * |
2.41x | EV / Sales 2025 * | 2.28x |
Free-Float |
25.03% | Yield 2024 * |
2.38% | Yield 2025 * | 2.45% |
Last Transcript: DSM-Firmenich
1 day | +0.82% | ||
1 week | -1.46% | ||
Current month | +0.82% | ||
1 month | -3.45% | ||
3 months | -14.34% | ||
6 months | -0.80% | ||
Current year | +13.91% |
Director | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 2019-12-31 | |
Ralf Schmeitz
DFI | Director of Finance/CFO | - | 2023-08-31 |
Ipek Ozsuer
CTO | Chief Tech/Sci/R&D Officer | 44 | 2023-04-30 |
Manager | Title | Age | Since |
---|---|---|---|
Thomas Leysen
CHM | Chairman | 64 | 2023-01-31 |
Director/Board Member | 62 | 2023-01-31 | |
André Pometta
BRD | Director/Board Member | 59 | 2023-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.82% | 12 M€ | +15.09% | - | |
0.51% | 10 M€ | +6.14% | - | |
0.22% | 4 M€ | -.--% | - | |
0.20% | 6 M€ | -.--% |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+0.82% | -1.46% | +21.83% | - | 29.1B | ||
-1.13% | -0.07% | +31.98% | +70.22% | 1,041B | ||
-0.02% | -0.25% | +0.63% | +163.78% | 240B | ||
-1.28% | -0.28% | +16.27% | +12.72% | 151B | ||
+0.35% | +0.77% | +13.56% | +18.45% | 81.95B | ||
-0.48% | +1.97% | +33.09% | -21.95% | 72.71B | ||
+1.36% | +0.77% | +175.81% | +769.22% | 49.1B | ||
+3.99% | +4.38% | +30.26% | +84.59% | 35.12B | ||
+0.52% | +4.91% | -39.71% | -59.65% | 31.42B | ||
0.00% | -0.31% | +2.80% | -13.76% | 21.35B | ||
Average | +0.41% | -0.12% | +28.65% | +113.74% | 175.36B | |
Weighted average by Cap. | -0.65% | -0.09% | +27.70% | +88.63% |
2024 * | 2025 * | |
---|---|---|
Net sales | 12.82B 13.45B 11.92B 10.64B 18.93B 1,140B 20.83B 148B 54.97B 467B 50.54B 49.41B 2,007B | 13.36B 14.02B 12.43B 11.09B 19.73B 1,188B 21.72B 154B 57.31B 487B 52.69B 51.51B 2,092B |
Net income | 471M 494M 438M 391M 695M 41.88B 765M 5.44B 2.02B 17.16B 1.86B 1.82B 73.73B | 811M 851M 755M 673M 1.2B 72.15B 1.32B 9.37B 3.48B 29.56B 3.2B 3.13B 127B |
Net Debt | 3.06B 3.21B 2.85B 2.54B 4.52B 272B 4.98B 35.38B 13.13B 112B 12.07B 11.8B 479B | 2.69B 2.82B 2.5B 2.23B 3.97B 239B 4.37B 31.1B 11.54B 98.09B 10.61B 10.38B 421B |
Date | Price | Change | Volume |
---|---|---|---|
24-12-02 | 104.80 CHF | +0.82% | 333,364 |
24-11-29 | 103.95 CHF | +0.19% | 419,183 |
24-11-28 | 103.75 CHF | -0.77% | 229,820 |
24-11-27 | 104.55 CHF | -0.33% | 341,188 |
24-11-26 | 104.90 CHF | -1.36% | 344,978 |
End-of-day quote Euronext Amsterdam, December 01, 2024
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- DSFIR Stock